- Home
- Publications
- Publication Search
- Publication Details
Title
Current Status of Clinical Trials on Tau Immunotherapies
Authors
Keywords
-
Journal
DRUGS
Volume 81, Issue 10, Pages 1135-1152
Publisher
Springer Science and Business Media LLC
Online
2021-06-08
DOI
10.1007/s40265-021-01546-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
- (2021) Günter U Höglinger et al. LANCET NEUROLOGY
- Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains
- (2020) Tamta Arakhamia et al. CELL
- Neuronally expressed anti-tau scFv prevents tauopathy-induced phenotypes in Drosophila models
- (2020) Senthilkumar Krishnaswamy et al. NEUROBIOLOGY OF DISEASE
- Tau immunotherapies: Lessons learned, current status and future considerations
- (2020) L.A. Sandusky-Beltran et al. NEUROPHARMACOLOGY
- Anti-tau scFvs targeted to the cytoplasm or secretory pathway variably modify pathology and neurodegenerative phenotypes
- (2020) Marshall S. Goodwin et al. MOLECULAR THERAPY
- CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease
- (2020) Kanta Horie et al. BRAIN
- Increased neuronal activity in motor cortex reveals prominent calcium dyshomeostasis in tauopathy mice
- (2020) Qian Wu et al. NEUROBIOLOGY OF DISEASE
- Characterization of tau binding by gosuranemab
- (2020) Richelle Sopko et al. NEUROBIOLOGY OF DISEASE
- Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model
- (2020) Dov B. Shamir et al. Frontiers in Neurology
- Cis pT231-tau Drives Neurodegeneration in Bipolar Disorder
- (2019) Roghayeh Naserkhaki et al. ACS Chemical Neuroscience
- It’s all about tau
- (2019) Cheril Tapia-Rojas et al. PROGRESS IN NEUROBIOLOGY
- Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy
- (2019) Erin E. Congdon et al. EBioMedicine
- The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans
- (2019) Jerrah K. Holth et al. SCIENCE
- Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules
- (2019) Benjamin Falcon et al. NATURE
- Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody
- (2019) Marie Albert et al. BRAIN
- Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
- (2019) Adam L Boxer et al. LANCET NEUROLOGY
- Single Domain Antibody Fragments as New Tools for the Detection of Neuronal Tau Protein in Cells and in Mice Studies
- (2019) Elian Dupré et al. ACS Chemical Neuroscience
- From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy
- (2019) Morvane Colin et al. ACTA NEUROPATHOLOGICA
- Targeting tauopathy with engineered tau-degrading intrabodies
- (2019) Gilbert Gallardo et al. Molecular Neurodegeneration
- Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders
- (2018) Brian Spencer et al. ACTA NEUROPATHOLOGICA
- The Neurotoxic Role of Extracellular Tau Protein
- (2018) Álvaro Sebastián-Serrano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tau Immunotherapies for Alzheimer’s Disease and Related Tauopathies: Progress and Potential Pitfalls
- (2018) Einar M. Sigurdsson JOURNAL OF ALZHEIMERS DISEASE
- Tau-targeting therapies for Alzheimer disease
- (2018) Erin E. Congdon et al. Nature Reviews Neurology
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau
- (2018) Jean-Philippe Courade et al. ACTA NEUROPATHOLOGICA
- Structures of filaments from Pick’s disease reveal a novel tau protein fold
- (2018) Benjamin Falcon et al. NATURE
- Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging
- (2018) Qian Wu et al. EBioMedicine
- Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice
- (2018) Francesca Vitale et al. Acta Neuropathologica Communications
- Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
- (2018) Claudia Cicognola et al. ACTA NEUROPATHOLOGICA
- FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease
- (2018) Petr Novak et al. Alzheimers Research & Therapy
- AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy
- (2017) Christina Ising et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
- (2017) Petr Novak et al. LANCET NEUROLOGY
- Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency
- (2017) Michael G. Agadjanyan et al. Molecular Neurodegeneration
- Cryo-EM structures of tau filaments from Alzheimer’s disease
- (2017) Anthony W. P. Fitzpatrick et al. NATURE
- Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation
- (2017) William A. McEwan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy
- (2017) Kiran Yanamandra et al. Science Translational Medicine
- MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice
- (2017) Hayk Davtyan et al. VACCINE
- Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae
- (2017) Onder Albayram et al. Nature Communications
- Tau passive immunization inhibits not only tau but also Aβ pathology
- (2017) Chun-ling Dai et al. Alzheimers Research & Therapy
- Extracellular Tau and Its Potential Role in the Propagation of Tau Pathology
- (2017) Kaoru Yamada Frontiers in Neuroscience
- Tau oligomers in cerebrospinal fluid in Alzheimer's disease
- (2017) Urmi Sengupta et al. Annals of Clinical and Translational Neurology
- Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
- (2017) Einar M. Sigurdsson JOURNAL OF ALZHEIMERS DISEASE
- Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice
- (2017) Hameetha Rajamohamedsait et al. Scientific Reports
- Internalization of tau antibody and pathological tau protein detected with a flow cytometry multiplexing approach
- (2016) Dov B. Shamir et al. Alzheimers & Dementia
- Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies
- (2016) Nicolas R. Barthélemy et al. JOURNAL OF ALZHEIMERS DISEASE
- Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets
- (2016) Tengfei Li et al. JOURNAL OF CONTROLLED RELEASE
- Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice
- (2016) Wencheng Liu et al. JOURNAL OF NEUROSCIENCE
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy
- (2016) Erin E. Congdon et al. Molecular Neurodegeneration
- Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement
- (2016) Seung-Hye Lee et al. Cell Reports
- Specific Targeting of Tau Oligomers in Htau Mice Prevents Cognitive Impairment and Tau Toxicity Following Injection with Brain-Derived Tau Oligomeric Seeds
- (2016) Diana L. Castillo-Carranza et al. JOURNAL OF ALZHEIMERS DISEASE
- Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory
- (2016) M. Fá et al. Scientific Reports
- Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines
- (2015) Di Xia et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Distinct Therapeutic Mechanisms of Tau Antibodies
- (2015) Kristen E. Funk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
- (2015) Asami Kondo et al. NATURE
- Tau and neurodegenerative disease: the story so far
- (2015) Khalid Iqbal et al. Nature Reviews Neurology
- Human secreted tau increases amyloid-beta production
- (2015) Jessica Bright et al. NEUROBIOLOGY OF AGING
- Tau Immunotherapy
- (2015) Einar M. Sigurdsson Neurodegenerative Diseases
- Tau immunotherapy for Alzheimer's disease
- (2015) Jan Torleif Pedersen et al. TRENDS IN MOLECULAR MEDICINE
- Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody
- (2015) Wenjie Luo et al. Scientific Reports
- Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
- (2015) Sethu Sankaranarayanan et al. PLoS One
- Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies
- (2015) Cristina d’Abramo et al. PLoS One
- Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease
- (2014) Ludovic Collin et al. BRAIN
- Neuronal activity regulates extracellular tau in vivo
- (2014) Kaoru Yamada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies
- (2014) Chun-ling Dai et al. JOURNAL OF NEURAL TRANSMISSION
- Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice
- (2014) Arne Ittner et al. JOURNAL OF NEUROCHEMISTRY
- Divergent CSF alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy
- (2014) D. Wagshal et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Antibody-Derived In Vivo Imaging of Tau Pathology
- (2014) S. Krishnaswamy et al. JOURNAL OF NEUROSCIENCE
- Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
- (2014) D. L. Castillo-Carranza et al. JOURNAL OF NEUROSCIENCE
- p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice
- (2014) Ken C. Walls et al. NEUROSCIENCE LETTERS
- First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- Characterization of tau oligomeric seeds in progressive supranuclear palsy
- (2014) Julia E Gerson et al. Acta Neuropathologica Communications
- Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
- (2013) Erin E. Congdon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
- (2013) Jiaping Gu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tau pathology and neurodegeneration
- (2013) Maria Grazia Spillantini et al. LANCET NEUROLOGY
- Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
- (2013) Kiran Yanamandra et al. NEURON
- Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity
- (2013) Cristina d’Abramo et al. PLoS One
- Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
- (2013) Clara Theunis et al. PLoS One
- Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease
- (2013) Jere E. Meredith Jr. et al. PLoS One
- Formation and Propagation of Tau Oligomeric Seeds
- (2013) Julia E. Gerson et al. Frontiers in Neurology
- Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice
- (2012) P. Fernandez-Vizarra et al. BRAIN
- Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach
- (2012) Nadege Zommer et al. Current Alzheimer Research
- Trans-cellular Propagation of Tau Aggregation by Fibrillar Species
- (2012) Najla Kfoury et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Constitutive secretion of tau protein by an unconventional mechanism
- (2012) Xiyun Chai et al. NEUROBIOLOGY OF DISEASE
- Tau as a Therapeutic Target for Alzheimers Disease
- (2011) A. Boutajangout et al. Current Alzheimer Research
- Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
- (2011) Xiyun Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases
- (2011) David T. Hickman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice
- (2011) K. Yamada et al. JOURNAL OF NEUROSCIENCE
- Post-translational modifications of tau protein: Implications for Alzheimer's disease
- (2011) Ludovic Martin et al. NEUROCHEMISTRY INTERNATIONAL
- Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
- (2011) Mian Bi et al. PLoS One
- Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an ex vivo Brain Slice Model
- (2011) Pavan K. Krishnamurthy et al. Frontiers in Psychiatry
- Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
- (2010) Lars M. Ittner et al. CELL
- Evidence for neuronal expression of functional Fc (ε and γ) receptors
- (2010) Hanneke van der Kleij et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
- (2010) H. Zempel et al. JOURNAL OF NEUROSCIENCE
- Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
- (2010) A. Boutajangout et al. JOURNAL OF NEUROSCIENCE
- Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
- (2010) Brian R. Hoover et al. NEURON
- Fcγ receptors contribute to pyramidal cell death in the mouse hippocampus following local kainic acid injection
- (2010) S. Suemitsu et al. NEUROSCIENCE
- Transmission and spreading of tauopathy in transgenic mouse brain
- (2009) Florence Clavaguera et al. NATURE CELL BIOLOGY
- Tau exon 10 alternative splicing and tauopathies
- (2008) Fei Liu et al. Molecular Neurodegeneration
- CSF biomarkers in frontotemporal lobar degeneration with known pathology
- (2008) H. Bian et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search